JP2021525512A5 - - Google Patents
Info
- Publication number
- JP2021525512A5 JP2021525512A5 JP2020566267A JP2020566267A JP2021525512A5 JP 2021525512 A5 JP2021525512 A5 JP 2021525512A5 JP 2020566267 A JP2020566267 A JP 2020566267A JP 2020566267 A JP2020566267 A JP 2020566267A JP 2021525512 A5 JP2021525512 A5 JP 2021525512A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- seq
- cdr2
- cdr3
- cdr1
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862678080P | 2018-05-30 | 2018-05-30 | |
| US62/678,080 | 2018-05-30 | ||
| PCT/US2019/034259 WO2019231957A1 (en) | 2018-05-30 | 2019-05-29 | Anti-abeta antibodies and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021525512A JP2021525512A (ja) | 2021-09-27 |
| JP2021525512A5 true JP2021525512A5 (cg-RX-API-DMAC7.html) | 2022-05-20 |
| JP7210612B2 JP7210612B2 (ja) | 2023-01-23 |
Family
ID=68694402
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020566267A Active JP7210612B2 (ja) | 2018-05-30 | 2019-05-29 | 抗aベータ抗体及びその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US11084873B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3801618A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7210612B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102523019B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN112601550B (cg-RX-API-DMAC7.html) |
| CA (1) | CA3100896C (cg-RX-API-DMAC7.html) |
| TW (1) | TWI721440B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019231957A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111201030B (zh) | 2017-07-25 | 2024-11-01 | 真和制药有限公司 | 通过阻断tim-3和其配体的相互作用治疗癌症 |
| KR20210124308A (ko) | 2019-01-30 | 2021-10-14 | 트루바인딩 아이엔씨. | 항-gal3 항체 및 이의 용도 |
| MX2022014786A (es) | 2020-05-26 | 2023-01-16 | Truebinding Inc | Metodos para tratar enfermedades inflamatorias mediante el bloqueo de galectina-3. |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ568012A (en) * | 2005-12-12 | 2012-07-27 | Ac Immune Sa | A beta 1-42 specific monoclonal antibodies with therapeutic properties |
| CN101325972B (zh) * | 2005-12-12 | 2020-06-16 | Ac免疫有限公司 | 具有治疗性质的Aβ1-42特异性单克隆抗体 |
| US8003097B2 (en) | 2007-04-18 | 2011-08-23 | Janssen Alzheimer Immunotherapy | Treatment of cerebral amyloid angiopathy |
| EP2527369A3 (en) * | 2007-09-13 | 2012-12-19 | University Of Zurich Prorektorat Forschung | Monoclonal amyloid beta (abeta)-specific antibody and uses thereof |
| CN104109208A (zh) * | 2007-11-14 | 2014-10-22 | 中外制药株式会社 | 使用抗gpr49抗体的癌症的诊断和治疗 |
| AU2008322523B2 (en) * | 2007-11-16 | 2013-10-10 | The Rockefeller University | Antibodies specific for the protofibril form of beta-amyloid protein |
| WO2011016238A1 (en) * | 2009-08-06 | 2011-02-10 | Immunas Pharma, Inc. | Antibodies that specifically bind to a beta oligomers and use thereof |
| EP2928494A4 (en) | 2012-12-07 | 2016-11-02 | Biogen Internat Neuroscience Gmbh | METHOD FOR REDUCING AMYLOIDER PLAQUE OF BRAIN WITH ANTI-ASS ANTIBODIES |
| US9879076B2 (en) * | 2013-03-15 | 2018-01-30 | Ramot At Tel Aviv University Ltd. | Methods and compositions with immune therapy for treatment of dementia |
| MX378944B (es) * | 2014-04-18 | 2025-03-10 | Univ New York State Res Found | Anticuerpos de antígeno anti-tf humanizado. |
| CA3004482A1 (en) * | 2015-11-09 | 2017-05-18 | Neil R. Cashman | N-terminal epitopes in amyloid beta and conformationally-selective antibodies thereto |
| PL3430397T3 (pl) * | 2016-03-14 | 2022-04-04 | Biogen International Neuroscience Gmbh | Oznaczenie fagocytozy zależnej od przeciwciał do wiarygodnych pomiarów wychwytu zagregowanych białek |
-
2019
- 2019-05-29 KR KR1020207034600A patent/KR102523019B1/ko active Active
- 2019-05-29 EP EP19811193.2A patent/EP3801618A4/en active Pending
- 2019-05-29 WO PCT/US2019/034259 patent/WO2019231957A1/en not_active Ceased
- 2019-05-29 CN CN201980036565.6A patent/CN112601550B/zh active Active
- 2019-05-29 JP JP2020566267A patent/JP7210612B2/ja active Active
- 2019-05-29 CA CA3100896A patent/CA3100896C/en active Active
- 2019-05-30 TW TW108118733A patent/TWI721440B/zh active
- 2019-05-30 US US16/426,585 patent/US11084873B2/en active Active